DISPOSITION OF THIORPHAN IN DOCA-SALT AND SPONTANEOUSLY HYPERTENSIVE RATS

被引:0
|
作者
SAKANE, Y
BERRY, C
HOPKINS, MF
SINGH, K
GHAI, RD
机构
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Thiorphan was administered intravenously (i. v.) at 10 mg/kg to conscious rats in two different models of hypertension to allow a comparison of pharmacokinetics. The two models were: 1) Deoxycorticosterone acetate (DOCA)-salt uninephrectomized rats; 2) Spontaneously hypertensive rats (SHR), and their respective normotensive controls; 3) Sprague-Dawley (SD) rats; and 4) Wistar-Kyoto rats (WKY). Pharmacokinetic parameters were calculated for total and unbound thiorphan in plasma. In normotensive SD and WKY rats, the volume of distribution, clearance and plasma protein binding of thiorphan were not significantly different. Furthermore, the apparent elimination half-life was not significantly different for total or unbound thiorphan amongst all models. The volume of distribution and plasma clearance for both unbound and total thiorphan, however, were lower in DOCA-salt rats when compared to normotensive control rats by 61-66% and 46-51%, respectively. In contrast, pharmacokinetic parameters for both unbound and total thiorphan were not significantly different between SHR and WKY rats. These results indicate that reduced clearance of thiorphan in DOCA-salt rats may be due to the co-administration of DOCA-salt or altered renal function of the hypertrophic remaining kidney and not solely due to hypertension.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [21] Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats
    Bae, Eun Hui
    Kim, In Jin
    Park, Jeong Woo
    Ma, Seong Kwon
    Lee, Jongun
    Kim, Soo Wan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S92 - S93
  • [22] ROLE OF CHLORIDE AND SODIUM IN DOCA-SALT HYPERTENSIVE RATS
    KUBOTA, Y
    KAWAHARA, J
    HSIEH, ST
    TSUJINO, T
    HATTORI, K
    SANO, H
    CIRCULATION, 1990, 82 (04) : 259 - 259
  • [24] STUDIES ON HYPERTENSION AND HYPOXIA IN SPONTANEOUSLY HYPERTENSIVE RATS (SHR) AND DEOXYCORTICOSTERONE ACETATE SALINE (DOCA-SALT) TREATED RATS
    BARELSKI, PM
    CROWELL, R
    CARDOSO, SS
    WOJCIECHOWSKI, NJ
    WOOD, WB
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 708 - 708
  • [25] PHARMACOKINETICS AND PHARMACODYNAMICS OF BUMETANIDE AFTER INTRAVENOUS AND ORAL-ADMINISTRATION TO SPONTANEOUSLY HYPERTENSIVE RATS AND DOCA-SALT INDUCED HYPERTENSIVE RATS
    HAN, KS
    LEE, SH
    LEE, MG
    KIM, ND
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1993, 14 (06) : 533 - 548
  • [26] Resveratroll attenuates cardiac remodelling in DOCA-salt hypertensive rats
    Weerasinghe, G
    Chan, V
    Brown, L
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 169 - 169
  • [27] CHLORTHALIDONE REDUCES VASCULAR HYPERRESPONSIVENESS IN DOCA-SALT HYPERTENSIVE RATS
    CABRAL, AM
    MUSSO, MN
    BISSOLI, NS
    CARVALHINHO, FB
    VASQUEZ, EC
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1992, 14 (04) : 667 - 683
  • [28] NALOXONE ATTENUATES DEVELOPMENT OF HYPERTENSION IN DOCA-SALT HYPERTENSIVE RATS
    ZHAI, SD
    MALVIN, RL
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1991, 13 (01) : 133 - 142
  • [29] Cicletanine Improves Endothelial Function in DOCA-Salt Hypertensive Rats
    Liang, Faquan
    Shryock, John
    HYPERTENSION, 2010, 56 (05) : E149 - E149
  • [30] Aortic NOS activity and expression in DOCA-salt hypertensive rats
    Collins, MH
    Sullivan, JC
    Williams, JM
    Pollock, DM
    Pollock, JS
    FASEB JOURNAL, 2003, 17 (04): : A523 - A524